Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 280
Filtrar
1.
Int J Tuberc Lung Dis ; 21(3): 270-277, 2017 03 01.
Artigo em Inglês | MEDLINE | ID: mdl-28225337

RESUMO

SETTING: Interferon-gamma (IFN-γ) release assays (IGRAs) play an important role in the diagnosis of Mycobacterium tuberculosis infection. However, in children with tuberculosis (TB), some studies have shown increased frequencies of false-negative or indeterminate IGRA results. OBJECTIVE: To analyse the spectrum of different cytokines to improve the diagnostic accuracy of IGRAs in latent tuberculous infection (LTBI) and active TB. DESIGN: We performed multiplex cytokine expression analysis of QuantiFERON® Gold In-Tube supernatants in children with active TB (n = 21) and disease-free contacts with (n = 15) and without LTBI (n = 12), to determine the sensitivity and specificity of the modified tests. RESULTS: Of 21 initial cytokines analysed, IFN-γ and six other candidates (interleukin [IL] 2, inducible protein 10 [IP-10], IL-13, IL-1α, tumour necrosis factor alpha [TNF-α] and granulocyte-macrophage colony-stimulating factor [GM-CSF]) were significantly more elevated in children with TB and those with LTBI than in the non-infected controls. Sensitivity and specificity were similar for IFN-γ and IL-2, but lower for the remaining candidates. Notably, a subset of candidates, including IP-10, showed M. tuberculosis antigen-induced specific expression in non-infected children. None of the candidates showed differences in expression between children with TB and those with LTBI. CONCLUSIONS: Our results did not suggest that alternative IGRA cytokines can distinguish between children with active TB and those with LTBI. IFN-γ and IL-2 showed comparable capacity in diagnosing M. tuberculosis infection in our study groups.


Assuntos
Citocinas/metabolismo , Testes de Liberação de Interferon-gama/métodos , Tuberculose Latente/diagnóstico , Tuberculose/diagnóstico , Adolescente , Criança , Pré-Escolar , Reações Falso-Positivas , Humanos , Lactente , Recém-Nascido , Interferon gama/metabolismo , Interleucina-2/metabolismo , Mycobacterium tuberculosis/isolamento & purificação , Sensibilidade e Especificidade
2.
Parasite Immunol ; 36(4): 141-9, 2014 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-24359133

RESUMO

More than 1·5 billion people are at risk of being infected with filarial nematodes worldwide. Therapy and control of transmission are mainly based on mass drug distribution. As these drugs have to be administered annually or biannually and might be loosing their efficacy, a vaccine against filariae is an alternative approach to chemotherapy. In the current study, we have analysed the potential of Brugia malayi heat shock protein 70 (BmHsp70) as a vaccine candidate in a murine helminth infection. Immunization of BALB/c mice with alum-precipitated recombinant BmHsp70 conferred partial protection against subsequent challenge infection with the rodent parasite Litomosoides sigmodontis. Immunization resulted in reduced numbers of larvae in the pleural cavity as well as reduced numbers of circulating microfilariae. Reduced parasite burden was associated with high titres of BmHsp70-specific antibodies and increased production of type I and II cytokines in response to L. sigmodontis antigen and BmHsp70. In summary, the immunization with BmHsp70 induced cellular and humoral immune responses and partially protected against L. sigmodontis in a challenge infection. Therefore, we hypothesize that BmHsp70 might be considered as a potential vaccine candidate for reduction in the incidence of B. malayi infections in future studies.


Assuntos
Antígenos de Helmintos/imunologia , Brugia Malayi/imunologia , Filariose/prevenção & controle , Filarioidea/imunologia , Proteínas de Choque Térmico HSP70/imunologia , Vacinas Sintéticas/administração & dosagem , Vacinas Sintéticas/imunologia , Animais , Anticorpos Anti-Helmínticos/sangue , Citocinas/biossíntese , Feminino , Filariose/imunologia , Filariose/parasitologia , Filarioidea/fisiologia , Camundongos , Camundongos Endogâmicos BALB C , Carga Parasitária , Vacinação
3.
Parasite Immunol ; 34(7): 388-93, 2012 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-22554071

RESUMO

About 225 million malaria cases have been reported worldwide in 2009, and one-third of the world's population is infected with parasitic helminths. As helminths and Plasmodium are co-endemic, concurrent infections frequently occur. Helminths have been shown to modulate the host's immune response; therefore, pre-existing helminth infections may interfere with the efficient immune response to Plasmodium. To study the interaction between helminths and Plasmodium, we established a murine model of co-infection using the gastrointestinal nematode Strongyloides ratti and Plasmodium yoelii. We show that a pre-existing Strongyloides infection slightly enhanced peak parasitemia and weight loss in P. yoelii-infected BALB/c mice, while disease progression was not altered in co-infected C57BL/6 mice. The Plasmodium-induced IFN-γ production and final clearance of Plasmodium infection were not affected by S. ratti co-infection in both C57BL/6 and BALB/c mice. Interestingly, the T helper cell (Th) 2 response induced by S. ratti was significantly suppressed upon P. yoelii co-infection. This suppressed Th2 response, however, was still sufficient to allow expulsion of S. ratti parasitic adults. Taken together, we provide evidence that simultaneous presence of helminth and protist parasites does not interfere with efficient host defence in our co-infection model although changes in Th responses were observed.


Assuntos
Malária/imunologia , Plasmodium yoelii/imunologia , Strongyloides ratti/imunologia , Estrongiloidíase/imunologia , Estrongiloidíase/parasitologia , Animais , Coinfecção/imunologia , Coinfecção/prevenção & controle , Modelos Animais de Doenças , Feminino , Tolerância Imunológica , Interferon gama/metabolismo , Malária/parasitologia , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Endogâmicos C57BL , Carga Parasitária , Parasitemia/parasitologia , Células Th2/imunologia
5.
Chirurg ; 79(2): 180-2, 2008 Feb.
Artigo em Alemão | MEDLINE | ID: mdl-17443302

RESUMO

Intrathoracic gastric herniation after laparoscopic antireflux surgery is a rare but well known phenomenon. It may occur during the early and late postoperative period. We report on a patient with early onset of dysphagia after surgery due to a tight wrap. Subsequent vomiting and dysphagia increased due to a gastric herniation. After gastroscopy and bougienage, tension pneumothorax developed. The context and relationships are illustrated and discussed referring to the current literature.


Assuntos
Transtornos de Deglutição/etiologia , Dispneia/etiologia , Fundoplicatura , Hérnia Hiatal/diagnóstico por imagem , Hérnia Hiatal/cirurgia , Laparoscopia , Pneumotórax/diagnóstico por imagem , Complicações Pós-Operatórias/etiologia , Gastropatias/diagnóstico por imagem , Transtornos de Deglutição/diagnóstico por imagem , Transtornos de Deglutição/cirurgia , Dilatação , Dispneia/diagnóstico por imagem , Dispneia/cirurgia , Perfuração Esofágica/diagnóstico por imagem , Perfuração Esofágica/cirurgia , Estenose Esofágica/diagnóstico por imagem , Estenose Esofágica/etiologia , Estenose Esofágica/cirurgia , Esofagoscopia , Hérnia , Humanos , Masculino , Pessoa de Meia-Idade , Pneumotórax/cirurgia , Complicações Pós-Operatórias/diagnóstico por imagem , Complicações Pós-Operatórias/cirurgia , Radiografia , Reoperação , Gastropatias/cirurgia , Deiscência da Ferida Operatória/diagnóstico por imagem , Deiscência da Ferida Operatória/cirurgia
6.
Trop Med Int Health ; 12(1): 89-96, 2007 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-17207152

RESUMO

OBJECTIVE: In view of technical and financial limitations in areas of endemicity, the current practice and recommendations for the laboratory diagnosis of Buruli ulcer disease (BUD) may have to be reconsidered. We reviewed diagnostic results in order to explore options for a modified, more practicable, cost-effective and timely approach to the laboratory diagnosis of BUD. METHODS: Diagnostic specimens from 161 clinically diagnosed BUD patients from four different treatment centres in Ghana were subjected to laboratory analysis. The positivity rates of the laboratory assays were compared. RESULTS: The number of laboratory-confirmed clinically diagnosed BUD cases with one positive confirmative test was 20% higher than that with two positive confirmative tests. The specificity of microscopy (MIC) and PCR was 96.6% and 100%, respectively. Subsequent analysis of specimens from surgically excised pre-ulcerative tissue-by-tissue MIC and tissue PCR rendered 65% laboratory-confirmed BUD cases. Subsequent analysis of diagnostic swabs from ulcerative lesions by swab smear MIC and swab PCR rendered 70% of laboratory-confirmed BUD cases. CONCLUSIONS: The specificity of the diagnostic tests used in this study suggests that one positive diagnostic test may be considered sufficient for the laboratory confirmation of BUD. Subsequent application of different diagnostic tests rendered a laboratory confirmation of 65% pre-ulcerative and of 70% ulcerative lesions. Implementation of a stepwise, subsequent analysis of diagnostic specimens will result in considerable cost saving compared with simultaneous testing of specimens by several diagnostic assays.


Assuntos
Infecções por Mycobacterium não Tuberculosas/diagnóstico , Mycobacterium ulcerans/isolamento & purificação , Dermatopatias Bacterianas/diagnóstico , Úlcera Cutânea/diagnóstico , Análise Custo-Benefício/métodos , Doenças Endêmicas , Gana/epidemiologia , Humanos , Microscopia/métodos , Infecções por Mycobacterium não Tuberculosas/epidemiologia , Infecções por Mycobacterium não Tuberculosas/microbiologia , Reação em Cadeia da Polimerase/métodos , Sensibilidade e Especificidade
7.
Trop Med Int Health ; 11(11): 1688-93, 2006 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-17054748

RESUMO

OBJECTIVE: To assure the quality of the laboratory diagnosis of Buruli ulcer disease; microscopy and PCR were subjected to external quality assurance (EQA). METHODS: Slides were read by test laboratory staff, followed by blinded re-reading by the controller. Parallel testing of PCR specimens was carried out at the local and external reference laboratory. Slides and PCR specimens with discordant results were subjected to a second reading/testing by the controller to determine the final result. For training purposes, slides and PCR specimens with discrepant results were subsequently re-read/re-tested under supervision at the test laboratory. RESULTS: Microscopy. First reading: concordance rate 82.9%, discordance rate 17.1%, percentage false negatives 27.1% (sensitivity 72.9%), percentage false positives 10.1% (specificity 89.9%). Second reading: concordance rate 97.9%, discordance rate 2.1%, percentage false negatives 4.2% (sensitivity 95.8%), percentage false positives 0.6% (specificity 99.4%). PCR. First testing: concordance rate 87.9%, discordance rate 12.1%, percentage false negatives 8.2% (sensitivity 91.8%), percentage false positives 19.1% (specificity 80.9%). Second testing: concordance rate 96.2%, discordance rate 3.8%, percentage false negatives 4.7% (sensitivity 95.3%), percentage false-positives 2.1% (specificity 97.9%). CONCLUSIONS: EQA identified deficiencies in the laboratory performance. Corrective action consisted in on-site training and reduced the number of false-negative and false-positive microscopy and PCR results.


Assuntos
Técnicas de Laboratório Clínico/normas , Infecções por Mycobacterium não Tuberculosas/diagnóstico , Mycobacterium ulcerans/isolamento & purificação , Controle de Qualidade , Reações Falso-Negativas , Reações Falso-Positivas , Gana/epidemiologia , Humanos , Funções Verossimilhança , Microscopia/métodos , Microscopia/normas , Infecções por Mycobacterium não Tuberculosas/epidemiologia , Reação em Cadeia da Polimerase/métodos , Reação em Cadeia da Polimerase/normas , Valor Preditivo dos Testes , Sensibilidade e Especificidade
8.
Clin Exp Immunol ; 145(2): 357-64, 2006 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-16879257

RESUMO

The protozoan parasite Trypanosoma cruzi circulates in the blood as trypomastigotes and invades a variety of cells to multiply intracellularly as amastigotes. The acute phase triggers an immune response that restricts the proliferation of the parasite. However, parasites are able to persist in different tissues causing the pathology of Chagas' disease. Natural killer (NK) cells play an important role in innate resistance to a variety of pathogens. In the present study we demonstrate that NK cells trigger trypanocidal mechanisms in infected L929 cells that are critically dependent on inducible nitric oxide (NO) synthase (iNOS) induction which is, to a major degree, triggered by interferon (IFN)-gamma provided by NK cells. This work provides a more detailed analysis of how NK cells as a part of the innate immune system participate in the control of parasites that reside intracellularly in fibroblast-like L929 cells.


Assuntos
Doença de Chagas/imunologia , Fibroblastos/imunologia , Células Matadoras Naturais/imunologia , Trypanosoma cruzi , Animais , Linhagem Celular , Indução Enzimática , Inibidores Enzimáticos/farmacologia , Fibroblastos/parasitologia , Guanidinas/farmacologia , Humanos , Interferon gama/genética , Interferon gama/imunologia , Interferon gama/metabolismo , Interleucina-12/imunologia , Ativação Linfocitária , Depleção Linfocítica , Camundongos , Camundongos Endogâmicos CBA , Óxido Nítrico Sintase Tipo II/antagonistas & inibidores , Óxido Nítrico Sintase Tipo II/metabolismo , Reação em Cadeia da Polimerase Via Transcriptase Reversa
9.
Oncol Rep ; 15(1): 227-30, 2006 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-16328060

RESUMO

Hepatocellular carcinoma (HCC) is highly resistant to chemotherapy, leading to a poor prognosis of advanced disease. Inhibitors of histone deacetylase (HDACi) induce re-differentiation in tumor cells and thereby re-establish sensitivity towards apoptotic stimuli. HDACi are entering the clinical stage of tumor treatment, and several substances are currently being tested in clinical trials to prove their efficacy in the treatment of leukemias and solid tumors. In this study, we investigated the impact of the HDACi valproic acid (VA) on TRAIL- and CD95-mediated apoptosis in hepatoma cells, as well as its sensitizing effect on a chemotherapeutic agent. Treatment of HepG2 cells with VA increased sensitivity to CD95-mediated apoptosis (4% apoptosis vs. 42%), and treatment with epirubicin (74% vs. 90% viability). Caspase-3 activity was significantly enhanced in cells treated with VA plus anti-CD95 antibodies compared to cells treated with antibodies alone. In parallel, VA strongly augmented the effect of TNF-related apoptosis-inducing ligand (TRAIL or Apo2 ligand) on HepG2 cells (10% vs. 58% apoptosis). VA induced down-regulation of cellular FLICE-inhibitory protein (c-FLIP/CASH, also known as Casper/iFLICE/FLAME-1/CLARP/MRIT/usurpin), providing a possible molecular mechanism underlying the increased sensitivity towards cell death-mediated apoptosis. HDAC inhibitors are a promising class for the treatment of leukemias. In addition, among other class members, VA deserves further evaluation as a treatment option for patients with advanced HCC.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Apoptose , Carcinoma Hepatocelular/tratamento farmacológico , Inibidores de Histona Desacetilases , Peptídeos e Proteínas de Sinalização Intracelular/metabolismo , Neoplasias Hepáticas/tratamento farmacológico , Ácido Valproico/uso terapêutico , Proteínas Reguladoras de Apoptose/uso terapêutico , Proteína Reguladora de Apoptosis Semelhante a CASP8 e FADD , Carcinoma Hepatocelular/enzimologia , Caspase 3 , Caspases/metabolismo , Regulação para Baixo , Resistencia a Medicamentos Antineoplásicos/efeitos dos fármacos , Epirubicina/administração & dosagem , Epirubicina/uso terapêutico , Humanos , Neoplasias Hepáticas/enzimologia , Glicoproteínas de Membrana/uso terapêutico , Receptores do Fator de Necrose Tumoral/agonistas , Ligante Indutor de Apoptose Relacionado a TNF , Fator de Necrose Tumoral alfa/uso terapêutico , Ácido Valproico/administração & dosagem , Receptor fas/metabolismo
10.
Trop Med Int Health ; 10(11): 1199-206, 2005 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-16262747

RESUMO

OBJECTIVE: The current standard of treatment of Buruli ulcer disease (BUD) is surgical excision of lesions. Excision size is determined macroscopically assuming the complete removal of all infected tissue. However, dissemination of infection beyond the excision margins into apparently healthy tissue, possibly associated with recurrences, cannot be excluded in this way. To assess the central to peripheral progression of Mycobacterium ulcerans infection and the mycobacterial infiltration of excision margins, excised tissue was examined for signs of infection. METHODS: 20 BUD lesions were excised in general anaesthesia including all necrotic and subcutaneous adipose tissue down to the fascia and at an average of 40 mm into the macroscopically unaffected tissue beyond the border of the lesion. Tissue samples were subjected to PCR and histopathology. RESULTS: Although the bacillary load decreased from central to peripheral, M. ulcerans infection was detected throughout all examined tissue specimens including the peripheral segments as well as excision margins of all patients. During the post-operative hospitalization period (averaging 2 months) no local recurrences were observed. CONCLUSION: Available data suggest a correlation of surgical techniques with local recurrences. The results of this study indicate the unnoticed early progression of mycobacterial infection into macroscopically healthy tissue. Thus, the removal of all infected tissue cannot always be verified visually by the surgeon. Provided that long-term follow up of patients with positive excision margins will establish the clinical relevance of these findings, on-site laboratory assessment of excised tissue in combination with follow up may contribute to reduce recurrence rates.


Assuntos
Infecções por Mycobacterium não Tuberculosas/microbiologia , Mycobacterium ulcerans/isolamento & purificação , Dermatopatias Bacterianas/microbiologia , Adolescente , Adulto , Criança , DNA Bacteriano/análise , Progressão da Doença , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Infecções por Mycobacterium não Tuberculosas/patologia , Infecções por Mycobacterium não Tuberculosas/cirurgia , Reação em Cadeia da Polimerase/métodos , Período Pós-Operatório , Dermatopatias Bacterianas/patologia , Dermatopatias Bacterianas/cirurgia , Úlcera Cutânea/microbiologia , Úlcera Cutânea/patologia , Úlcera Cutânea/cirurgia
11.
J Clin Microbiol ; 43(1): 271-6, 2005 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-15634982

RESUMO

After tuberculosis and leprosy, Buruli ulcer (BU), caused by Mycobacterium ulcerans, is the third most common mycobacterial disease in immunocompetent humans. The disease occurs in tropical countries, with foci in West Africa, Central Africa, and the western Pacific. BU is defined as an infectious disease involving the skin and the subcutaneous adipose tissue characterized by a painless nodule, papule, plaque, or edema, evolving into a painless ulcer with undermined edges and often leading to invalidating sequelae. Due to the fundamental lack of understanding of modes of transmission, disease control in endemic countries is limited to early case detection through improved active surveillance and surgical treatment. The laboratory confirmation of BU is complicated by the absence of a diagnostic "gold standard." Therefore, misclassification and delayed diagnosis of BU may occur frequently, causing a considerable socioeconomic impact in terms of treatment costs due to prolonged hospitalization. In order to respond to the urgent need to develop reliable tools for early case detection and to overcome technical difficulties accompanying the implementation of diagnostic PCR procedures in tropical countries, a dry-reagent-based PCR formulation for the detection of M. ulcerans in diagnostic specimens has been developed at the Bernhard Nocht Institute for Tropical Medicine. Following technical and clinical validation, the assay has been successfully installed and field tested at the Kumasi Centre for Collaborative Research in Tropical Medicine, Kumasi, Ghana. Preliminary results show an excellent diagnostic sensitivity of >95%.


Assuntos
Doenças Endêmicas , Infecções por Mycobacterium não Tuberculosas/diagnóstico , Infecções por Mycobacterium não Tuberculosas/epidemiologia , Mycobacterium ulcerans/isolamento & purificação , Reação em Cadeia da Polimerase/métodos , Clima Tropical , Liofilização , Humanos , Indicadores e Reagentes , Infecções por Mycobacterium não Tuberculosas/microbiologia , Mycobacterium ulcerans/classificação , Mycobacterium ulcerans/genética , Sensibilidade e Especificidade
12.
Artigo em Alemão | MEDLINE | ID: mdl-15650907

RESUMO

At the end of the twentieth century, tropical infectious diseases increased despite earlier successes of eradication campaigns. As a global warming of 1.4-5.8 degrees C is anticipated to occur by 2100, mainly the vector-borne tropical diseases that are particularly sensitive to climate are expected to spread. Although biological reasons seemingly support this hypothesis, ecological and socioeconomic factors have in the past proven to be stronger driving forces for the spread of infectious disease than climate.


Assuntos
Doenças Transmissíveis/transmissão , Efeito Estufa , Animais , Vetores de Doenças , Doenças Endêmicas , Humanos , Medição de Risco , Clima Tropical , Medicina Tropical , Zoonoses/transmissão
13.
Eur J Cardiothorac Surg ; 26(6): 1220-2, 2004 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-15541988

RESUMO

Myelolipoma commonly occurs in the adrenal gland and is composed of both adipose tissue and normal hematopoietic elements. Extraadrenal myelolipoma may occur in the retroperitoneum, stomach, liver, lung, and in 3% of cases even in the mediastinum. We present a 65-year-old female patient with unspecific clinical symptoms. Routine chest roentgenograms revealed bilateral widening of the posterior mediastinum. Computed tomography showed bilateral, paravertebral lesions of 4.5 and 6.5 cm in diameter, respectively. After surgical removal, bilateral thoracic myelolipoma was pathomorphologically diagnosed. The imaging differential diagnosis of bilateral solid lesions in the posterior mediastinum including lymph node metastases, lymphomas, neurogenic tumors and extramedullary hematopoietic tumors is discussed.


Assuntos
Neoplasias do Mediastino/patologia , Mielolipoma/patologia , Idoso , Diagnóstico Diferencial , Feminino , Humanos , Neoplasias do Mediastino/diagnóstico por imagem , Mielolipoma/diagnóstico por imagem , Radiografia
14.
Parasite Immunol ; 26(1): 19-28, 2004 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-15198642

RESUMO

Infection with Trypanosoma cruzi causes a profound suppression of T cell responsiveness to polyclonal or antigenic stimuli. In this study, we quantified expression of the negative T cell regulatory molecule CTLA-4 in T. cruzi infected mice and analysed its influence on the immune suppression. Levels of splenic CTLA-4 expression were highest around day 10 after infection, reaching 5% in resistant B6D2F1 mice, but exceeding 10% of CD4(+) T cells in C57BL/6 mice that were susceptible to mortal disease. The proliferative response of explanted splenocytes to CD3-mediated stimulation was strongly suppressed in both the susceptible and the resistant strains. Blockade of CTLA-4 in vitro with a monoclonal antibody affected neither proliferative response nor cytokine production (IFN-gamma, IL-4 and IL-2) by splenic T cells from infected C57BL/6 mice. Treatment of mice with anti-CTLA-4 antibody on the day of infection decreased IFN-gamma production and reduced mortality by about 50%. We conclude that high CTLA-4 expression is a hallmark of severe disease in murine T. cruzi infection, and that CTLA-4 has a regulative influence at the early stages during priming of the immune reaction to the parasite, augmenting a strong Th1-biased response.


Assuntos
Antígenos de Diferenciação/biossíntese , Antígenos de Diferenciação/imunologia , Doença de Chagas/imunologia , Trypanosoma cruzi/imunologia , Animais , Antígenos CD , Antígenos CD4/análise , Linfócitos T CD4-Positivos/imunologia , Linfócitos T CD4-Positivos/metabolismo , Antígenos CD8/análise , Linfócitos T CD8-Positivos/imunologia , Linfócitos T CD8-Positivos/metabolismo , Antígeno CTLA-4 , Doença de Chagas/parasitologia , Modelos Animais de Doenças , Regulação da Expressão Gênica , Interferon gama/análise , Interferon gama/biossíntese , Interleucina-2/análise , Interleucina-2/biossíntese , Interleucina-4/análise , Interleucina-4/biossíntese , Subpopulações de Linfócitos/imunologia , Subpopulações de Linfócitos/metabolismo , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Baço/citologia , Baço/imunologia , Trypanosoma cruzi/patogenicidade
15.
Cesk Fysiol ; 53(4): 142-51, 2004.
Artigo em Eslovaco | MEDLINE | ID: mdl-15704738

RESUMO

Renin-angiotensin system (RAS) have been extensively studied in last few decades. RAS regulates blood pressure, water and electrolytes balance. The disorders in function of RAS may play a potential role in development of some complex diseases like: hypertension, myocardial infarction, stroke, nephropathies and renal failure, chronic obstruction pulmonary disease and many more. RAS may take part in formation and progression of these diseases. In this work we focus on molecular biology of RAS and polymorphisms of RAS genes.


Assuntos
Sistema Renina-Angiotensina , Angiotensinas/genética , Angiotensinas/fisiologia , Animais , Humanos , Peptidil Dipeptidase A/genética , Peptidil Dipeptidase A/fisiologia , Polimorfismo Genético , Receptores de Angiotensina/genética , Receptores de Angiotensina/fisiologia , Sistema Renina-Angiotensina/genética , Sistema Renina-Angiotensina/fisiologia
16.
Scand J Immunol ; 58(3): 306-11, 2003 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-12950676

RESUMO

CD83 is a marker molecule for mature dendritic cells (DCs) but is also substantially expressed on activated T cells in humans and mice. Its function is unknown, but CD83 knockout mice show an impaired thymic maturation of CD4-positive cells and soluble CD83 inhibits partially antigen-specific responses in vitro pointing to a role of CD83 in the immune system. Here we show that CD83-positive T cells produce strongly increased amounts of interferon-gamma and interleukin-2. In contrast, constitutive expression of CD83 on DCs alters neither the activation of DCs following addition of lipopolysaccharide nor the ability to present antigenic peptides. Thus, the expression of CD83 on T cells has direct functional consequences for tuning the activation threshold.


Assuntos
Imunoglobulinas/imunologia , Ativação Linfocitária/imunologia , Glicoproteínas de Membrana/imunologia , Linfócitos T/imunologia , Animais , Antígenos CD , Diferenciação Celular/imunologia , Células Dendríticas/imunologia , Proteínas do Ovo/imunologia , Ensaio de Imunoadsorção Enzimática , Feminino , Imunoglobulinas/biossíntese , Interferon gama/biossíntese , Interferon gama/imunologia , Interleucina-2/biossíntese , Interleucina-2/imunologia , Masculino , Glicoproteínas de Membrana/biossíntese , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Endogâmicos C57BL , Camundongos Transgênicos , Ovalbumina/imunologia , Fragmentos de Peptídeos , Linfócitos T/metabolismo , Antígeno CD83
17.
Genes Immun ; 4(5): 321-5, 2003 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-12847546

RESUMO

Chagas' disease is caused by the protozoan parasite Trypanosoma cruzi and commonly modelled in inbred mice. Susceptibility of mouse strains to experimental infection varies considerably. We quantified parasite tissue burdens in resistant and susceptible strains by real time PCR and applied a backcross strategy to map the genomic loci linked to susceptibility in inbred mice. Resistant B6D2F1 mice were backcrossed with susceptible C57BL/6 mice, and 46 of a total 192 offspring died after infection. Their genomes were scanned with microsatellite markers. One region on chromosome 17 was significantly linked to susceptibility, while another on chromosome 5 was suggestive of linkage.


Assuntos
Antígenos de Protozoários/genética , Doença de Chagas/genética , Mapeamento Cromossômico , Modelos Animais de Doenças , Trypanosoma cruzi/imunologia , Animais , Cruzamentos Genéticos , Primers do DNA , Ligação Genética/genética , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Endogâmicos DBA , Repetições de Microssatélites/genética
18.
Scand J Immunol ; 55(4): 329-35, 2002 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-11967113

RESUMO

Lipopolysaccharide (LPS) can activate human and murine T cells in vivo and in vitro. Here we analysed the effects of LPS on T cells with defined specificities in T-cell receptor (TCR)-transgenic systems. LPS rapidly induced high amounts of interferon (IFN)-gamma in a subpopulation of purified T cells from DO11.10 (OVA323-339/H2-Ad) and OT-1 (OVA257-264/H2-Kb) mice when coincubated with antigen-pulsed peritoneal exudate cells (PECs). LPS induced IFN-gamma in T cell cultures even when the number of antigenic major histocompatibility complex (MHC) class-I complexes was too small to stimulate the T cells. LPS, thus, overruled the unresponsiveness of the otherwise 'antigen-ignorant' T cells. The release of IFN-gamma strictly correlates with the PECs' ability to produce interleukin (IL)-12. In contrast to the induction of IFN-gamma, antigen-specific IL-2 secretion and proliferation of T cells were rather decreased in the presence of LPS. Only very few IFN-gamma-secreting natural killer (NK) cells and natural killer T (NKT) cells in the given experimental system could be detected using intracellular fluorescence-activated cell sorter (FACS) staining. Taken together, our results indicate that LPS has the potential to activate quiescent T cells and to specifically induce IFN-gamma in CD4 and CD8 T cells. This may have direct consequences for the activation of autoreactive T cells following bacterial infections.


Assuntos
Antígenos/imunologia , Linfócitos T CD4-Positivos/imunologia , Linfócitos T CD8-Positivos/imunologia , Interferon gama/biossíntese , Lipopolissacarídeos/farmacologia , Ativação Linfocitária/efeitos dos fármacos , Animais , Interleucina-12/fisiologia , Receptores de Lipopolissacarídeos/fisiologia , Camundongos , Receptores de Antígenos de Linfócitos T/fisiologia
19.
Clin Exp Immunol ; 126(1): 143-50, 2001 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-11678911

RESUMO

CTLA-4 (CD152) is a surface molecule of activated T cells with sequence homology to CD28. Both molecules bind to the same ligands, B7.1 (CD80) and B7.2 (CD86) but have antagonistic functions. While CD28 is an important costimulator, CTLA-4 has an essential inhibitory function in maintaining the homeostasis of the immune system. Furthermore, CTLA-4 has a role in inducing a Th1 response and suppressing Th2 cytokines, an effect which is antagonized by CD28. Many autoimmune diseases are characterized by an overwhelming production of Th1 cytokines. Recently, the predominance of the Th1 cytokine pattern has been directly observed in the granulomatous inflammation of patients with Wegener's granulomatosis. The balance between CD28 and CTLA-4 expression by T lymphocytes could be a factor in the pathogenesis of autoimmune diseases. Down regulation of CD28 predominantly on CD8+ T cells has been described in Wegner's granulomatosis; however, analysis of CTLA-4 is complicated by its low expression levels. Here we have used potent signal enhancement to study CTLA-4 on PBMC in patients with Wegener's granulomatosis (n = 25) in comparison with healthy controls (n = 19). Expression levels of CTLA-4 were significantly increased selectively on CD4+ and possibly also on CD4-/CD8- T cells in Wegener's granulomatosis. High CTLA-4 expression by T lymphocytes was associated with more severe disease. In contrast, after stimulation with the mitogen PHA, CTLA-4 levels were strongly increased on T cells from controls but in T cells from Wegener's granulomatosis patients this response was severely impaired. Interestingly, while CTLA-4 was seen exclusively on T cells in control individuals, about half of the Wegener's patients showed CTLA-4 expression by a fraction of peripheral B lymphocytes. CTLA-4 positive B cells in the periphery were associated with less acute disease.


Assuntos
Antígenos de Diferenciação/biossíntese , Linfócitos B/imunologia , Granulomatose com Poliangiite/metabolismo , Imunoconjugados , Linfócitos T/imunologia , Abatacepte , Adulto , Idoso , Antígenos CD , Linfócitos B/efeitos dos fármacos , Antígeno CTLA-4 , Células Cultivadas , Feminino , Granulomatose com Poliangiite/diagnóstico , Humanos , Ativação Linfocitária , Masculino , Pessoa de Meia-Idade , Mitógenos/farmacologia , Linfócitos T/efeitos dos fármacos
20.
J Virol ; 75(19): 9252-61, 2001 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-11533187

RESUMO

Herpesvirus saimiri is capable of transforming T lymphocytes of various primate species to stable growth in culture. The interaction of the T-cellular tyrosine kinase p56(lck) with the transformation-associated viral protein Tip has been shown before to activate the kinase and provides one model for the T-cell-specific transformation by herpesvirus saimiri subgroup C strains. In contrast to other primate species, squirrel monkeys (Saimiri sciureus) are naturally infected with the virus without signs of lymphoma or other disease. Although the endogenous virus was regularly recovered from peripheral blood cells from squirrel monkeys, we observed that the T cells lost the virus genomes in culture. Superinfection with virus strain C488 did not induce growth transformation, in contrast to parallel experiments with T cells of other primate species. Surprisingly, p56(lck) was enzymatically inactive in primary T-cell lines derived from different squirrel monkeys, although the T cells reacted appropriately to stimulatory signals. The cDNA sequence revealed minor point mutations only, and transfections in COS-7 cells demonstrated that the S. sciureus lck gene codes for a functional enzyme. In S. sciureus, the tyrosine kinase p56(lck) was not activated after T-cell stimulation and enzymatic activity could not be induced by Tip of herpesvirus saimiri C488. However, the suppression of p56(lck) was partially released after administration of the phosphatase inhibitor pervanadate. This argues for unique species-specific conditions in T cells of S. sciureus which may interfere with the transforming activity and pathogenicity of herpesvirus saimiri subgroup C strains in their natural host.


Assuntos
Infecções por Herpesviridae/imunologia , Herpesvirus Saimiriíneo 2/fisiologia , Proteína Tirosina Quinase p56(lck) Linfócito-Específica/imunologia , Linfócitos T/imunologia , Linfócitos T/virologia , Infecções Tumorais por Vírus/imunologia , Sequência de Aminoácidos , Animais , Transformação Celular Viral , Regulação para Baixo , Infecções por Herpesviridae/enzimologia , Humanos , Proteína Tirosina Quinase p56(lck) Linfócito-Específica/metabolismo , Dados de Sequência Molecular , Saimiri , Alinhamento de Sequência , Linfócitos T/enzimologia , Replicação Viral
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA